ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

FGEN FibroGen Inc

1.02
0.00 (0.00%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
FibroGen Inc FGEN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1.02 14:00:00
Open Price Low Price High Price Close Price Previous Close
1.04 0.9754 1.06 1.04 1.02
more quote information »

Recent News

Date Time Source Heading
25/4/202406:02GLOBEFibroGen Announces Clinical Data from Dose Escalation Phase..
03/4/202408:46GLOBEFibroGen Announces Topline Results from Phase 1 Monotherapy..
26/3/202422:00GLOBEFibroGen to Present at 23rd Annual Needham Virtual..
11/3/202422:00GLOBEFibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer
09/3/202411:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202411:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202411:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202408:08EDGAR2Form 8-K - Current report
27/2/202408:06GLOBEFibroGen Reports Fourth Quarter and Full Year 2023 Financial..
27/2/202408:05GLOBEFibroGen Regains All Rights to Roxadustat from AstraZeneca..
24/2/202412:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202412:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202412:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202423:00GLOBEFibroGen to Report Fourth Quarter and Full Year 2023..
15/2/202407:37EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202412:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202423:00GLOBEFibroGen To Host Part I of Virtual KOL Investor Event Series..
25/1/202423:00GLOBEFibroGen Announces Completion of the Pamrevlumab Arm in..
27/12/202311:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202308:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202308:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202308:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202309:02GLOBEFibroGen Presents Data from Phase 3 MATTERHORN Trial of..
07/11/202308:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202308:05EDGAR2Form 8-K - Current report
07/11/202308:01GLOBEFibroGen Reports Third Quarter 2023 Financial Results
04/11/202307:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/10/202307:30EDGAR2Form 8-K - Current report
23/10/202322:00GLOBEFibroGen to Report Third Quarter 2023 Financial Results
26/9/202309:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/9/202307:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/9/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/9/202306:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/9/202306:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202310:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202310:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202322:55EDGAR2Form 8-K - Current report
02/9/202309:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/9/202309:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/9/202307:31EDGAR2Form 144 - Report of proposed sale of securities
30/8/202307:14EDGAR2Form 8-K - Current report
30/8/202306:15GLOBEFibroGen Announces Topline Results from LELANTOS-2, a Phase..
15/8/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202307:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202309:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202306:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202306:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202306:06EDGAR2Form 8-K - Current report
08/8/202306:01GLOBEFibroGen Reports Second Quarter 2023 Financial Results
05/8/202306:42EDGAR2Form 144 - Report of proposed sale of securities

Your Recent History

Delayed Upgrade Clock